$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is the Bangladeshi version of Eltrombopag/Eltrombopag an economical choice for patients?
2026-02-01 22:25:32
Check Details
Eltrombopag/eltrombopag, available in various versions, is an important drug for the treatment of thrombocytopenia
2026-02-01 22:25:32
Check Details
When to consider dose reduction during long-term use of eltrombopag/eltrombopag
2026-02-01 22:25:32
Check Details
Eltrombopag/eltrombopag clinical trial results
2026-02-01 22:25:32
Check Details
The last transaction price of Eltrombopag/Eltrombopag ethanolamine tablets
2026-02-01 22:25:32
Check Details
What patients should take Eltrombopag/Eltrombopag ethanolamine tablets?
2026-02-01 22:25:32
Check Details
Why are Eltrombopag/Eltrombopag ethanolamine tablets so expensive?
2026-02-01 22:25:32
Check Details
Will Eltrombopag/Eltrombopag cause platelet loss if you stop taking it?
2026-02-01 22:25:32
Check Details
Is Eltrombopag/Eltrombopag a hormonal drug?
2026-02-01 22:25:32
Check Details
Treatment of Thrombocytopenia: The Price of Eltrombopag/Eltrombopag Ethanolamine Tablets Revealed
2026-02-01 22:25:32
Check Details
Applicable diseases and therapeutic effects of Eltrombopag/Eltrombopag Ethanolamine Tablets
2026-02-01 22:25:32
Check Details
Why patients have to pay so much for eltrombopag/eltrombopag ethanolamine tablets
2026-02-01 22:25:32
Check Details
1
2
...
552
553
554
555
556
557
558
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
2
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
3
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
4
ROS and Cancer: The Potential of Natural Antioxidants
5
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
6
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
7
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
8
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
9
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
10
From Causes to Treatments—Exploring Medical Breakthroughs
11
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
12
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship